ProShare Advisors’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79.6K Sell
32,638
-5,396
-14% -$10.8K ﹤0.01% 1736
2025
Q4
$52.1K Buy
38,034
+4,204
+12% +$5.54K ﹤0.01% 1949
2025
Q3
$41.9K Sell
33,830
-5,430
-14% -$6.47K ﹤0.01% 1949
2025
Q2
$44.4K Buy
39,260
+2,014
+5% +$2.68K ﹤0.01% 2005
2025
Q1
$54.4K Sell
37,246
-8,836
-19% -$16.7K ﹤0.01% 1943
2024
Q4
$98.2K Buy
46,082
+9,388
+26% +$23.2K ﹤0.01% 2080
2024
Q3
$103K Buy
36,694
+11,149
+44% +$29.7K ﹤0.01% 1878
2024
Q2
$59.5K Sell
25,545
-3,224
-11% -$9.51K ﹤0.01% 1726
2024
Q1
$129K Buy
28,769
+2,377
+9% +$9.92K ﹤0.01% 1780
2023
Q4
$84.7K Buy
26,392
+4,759
+22% +$13.5K ﹤0.01% 1803
2023
Q3
$68.6K Buy
21,633
+1,509
+7% +$6.61K ﹤0.01% 1687
2023
Q2
$100K Buy
20,124
+726
+4% +$3.93K ﹤0.01% 1698
2023
Q1
$95.8K Sell
19,398
-2,783
-13% -$17.8K ﹤0.01% 1599
2022
Q4
$140K Buy
22,181
+1,297
+6% +$12K ﹤0.01% 1582
2022
Q3
$225K Sell
20,884
-475
-2% -$6.46K ﹤0.01% 1332
2022
Q2
$243K Sell
21,359
-7,862
-27% -$69.8K ﹤0.01% 1343
2022
Q1
$266K Sell
29,221
-7,554
-21% -$78.7K ﹤0.01% 1711
2021
Q4
$549K Sell
36,775
-4,062
-10% -$71.7K ﹤0.01% 1378
2021
Q3
$1.05M Sell
40,837
-4,639
-10% -$110K ﹤0.01% 891
2021
Q2
$1.19M Buy
45,476
+10,365
+30% +$296K ﹤0.01% 936
2021
Q1
$1.24M Buy
35,111
+332
+1% +$11.2K ﹤0.01% 877
2020
Q4
$878K Buy
34,779
+4,627
+15% +$151K ﹤0.01% 944
2020
Q3
$1.14M Buy
30,152
+2,493
+9% +$94K 0.01% 688
2020
Q2
$1.18M Buy
27,659
+7,667
+38% +$277K 0.01% 664
2020
Q1
$389K Sell
19,992
-12,850
-39% -$306K ﹤0.01% 796
2019
Q4
$853K Buy
+32,842
New +$905K ﹤0.01% 851

Other funds holding ALLO